DEEPNOID（A315640）株式概要株式会社ディープノイドは、医療用人工知能ソリューションを提供しています。 詳細A315640 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性6/6配当金0/6リスク分析過去1年間で株主の希薄化は大幅に進んだ 過去5年間で収益は年間1.5%減少しました。 意味のある時価総額がありません ( ₩48B )意味のある収益がありません ( ₩7B )すべてのリスクチェックを見るA315640 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW464,325 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA464,325 investors already sharing narrativesYour Fair Value₩Current Price₩1.65k66.9% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-13b45b2016201920222025202620282031Revenue ₩45.0bEarnings ₩5.6bAdvancedSet Fair ValueView all narrativesDEEPNOID Inc. 競合他社Coreline SoftSymbol: KOSDAQ:A384470Market cap: ₩47.0bBIT ComputerSymbol: KOSDAQ:A032850Market cap: ₩62.4bCarelabsLtdSymbol: KOSDAQ:A263700Market cap: ₩37.1bCJ BioscienceSymbol: KOSDAQ:A311690Market cap: ₩48.3b価格と性能株価の高値、安値、推移の概要DEEPNOID過去の株価現在の株価₩1,645.0052週高値₩5,860.0052週安値₩1,120.00ベータ0.601ヶ月の変化27.32%3ヶ月変化-46.07%1年変化-69.54%3年間の変化-87.22%5年間の変化-85.28%IPOからの変化-86.94%最新ニュースNew Risk • Aug 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.5% per year over the past 5 years. Shareholders have been substantially diluted in the past year (30% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (₩6.9b revenue, or US$4.8m). Market cap is less than US$100m (₩50.8b market cap, or US$35.9m).New Risk • Jun 01New major risk - Revenue and earnings growthEarnings have declined by 1.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.5% per year over the past 5 years. Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₩6.9b revenue, or US$4.6m). Market cap is less than US$100m (₩83.1b market cap, or US$55.1m).New Risk • Apr 01New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₩7.5b (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₩7.5b revenue, or US$5.0m). Market cap is less than US$100m (₩96.9b market cap, or US$64.3m).New Risk • Jan 03New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 31% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩97.2b market cap, or US$67.4m).お知らせ • Dec 16DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 19.720256 billion.DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 19.720256 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 6,108,016 Price\Range: KRW 2885 Security Name: Common Stock Security Type: Common Stock Securities Offered: 727,428 Price\Range: KRW 2885 Transaction Features: Rights Offering分析記事 • Dec 12Does DEEPNOID (KOSDAQ:315640) Have A Healthy Balance Sheet?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...最新情報をもっと見るRecent updatesNew Risk • Aug 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.5% per year over the past 5 years. Shareholders have been substantially diluted in the past year (30% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (₩6.9b revenue, or US$4.8m). Market cap is less than US$100m (₩50.8b market cap, or US$35.9m).New Risk • Jun 01New major risk - Revenue and earnings growthEarnings have declined by 1.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.5% per year over the past 5 years. Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₩6.9b revenue, or US$4.6m). Market cap is less than US$100m (₩83.1b market cap, or US$55.1m).New Risk • Apr 01New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₩7.5b (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₩7.5b revenue, or US$5.0m). Market cap is less than US$100m (₩96.9b market cap, or US$64.3m).New Risk • Jan 03New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 31% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩97.2b market cap, or US$67.4m).お知らせ • Dec 16DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 19.720256 billion.DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 19.720256 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 6,108,016 Price\Range: KRW 2885 Security Name: Common Stock Security Type: Common Stock Securities Offered: 727,428 Price\Range: KRW 2885 Transaction Features: Rights Offering分析記事 • Dec 12Does DEEPNOID (KOSDAQ:315640) Have A Healthy Balance Sheet?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...New Risk • Nov 29New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩9.7b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩9.7b free cash flow). Minor Risk Market cap is less than US$100m (₩87.7b market cap, or US$59.7m).お知らせ • Sep 09DEEPNOID Inc. has filed a Follow-on Equity Offering in the amount of KRW 27.000004 billion.DEEPNOID Inc. has filed a Follow-on Equity Offering in the amount of KRW 27.000004 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 6,835,444 Price\Range: KRW 3950 Discount Per Security: KRW 35.55 Transaction Features: Rights OfferingNew Risk • Jul 04New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩136.2b (US$100.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩17b free cash flow). Minor Risks Share price has been volatile over the past 3 months (9.4% average weekly change). Market cap is less than US$100m (₩136.2b market cap, or US$100.0m).分析記事 • Mar 31Is DEEPNOID (KOSDAQ:315640) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...New Risk • Mar 28New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩141.7b (US$96.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (₩141.7b market cap, or US$96.5m).お知らせ • Mar 01DEEPNOID Inc., Annual General Meeting, Mar 28, 2025DEEPNOID Inc., Annual General Meeting, Mar 28, 2025, at 09:30 Tokyo Standard Time. Location: conference room, guro-gu, seoul South KoreaReported Earnings • Nov 15Third quarter 2024 earnings released: ₩76.00 loss per share (vs ₩86.00 loss in 3Q 2023)Third quarter 2024 results: ₩76.00 loss per share. Revenue: ₩3.98b (up ₩3.49b from 3Q 2023). Net loss: ₩1.70b (loss widened 5.3% from 3Q 2023). Revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Healthcare Services industry in Asia.New Risk • Aug 02New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩125.8b (US$92.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). Revenue is less than US$5m (₩2.1b revenue, or US$1.6m). Market cap is less than US$100m (₩125.8b market cap, or US$92.1m).New Risk • Nov 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risks Shareholders have been diluted in the past year (16% increase in shares outstanding). Revenue is less than US$5m (₩3.2b revenue, or US$2.5m).お知らせ • Oct 26DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 22.59 billion.DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 22.59 billion. Security Name: Common Shares Security Type: Common Stock Securities Offered: 1,500,000 Price\Range: KRW 15060 Transaction Features: Subsequent Direct ListingBoard Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.株主還元A315640KR Healthcare ServicesKR 市場7D-4.3%-10.5%-1.4%1Y-69.5%-19.0%106.4%株主還元を見る業界別リターン: A315640過去 1 年間で-19 % の収益を上げたKR Healthcare Services業界を下回りました。リターン対市場: A315640は、過去 1 年間で106.4 % のリターンを上げたKR市場を下回りました。価格変動Is A315640's price volatile compared to industry and market?A315640 volatilityA315640 Average Weekly Movement13.6%Healthcare Services Industry Average Movement11.6%Market Average Movement9.7%10% most volatile stocks in KR Market17.6%10% least volatile stocks in KR Market5.1%安定した株価: A315640 、 KR市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: A315640の 週次ボラティリティ ( 14% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2008n/aWoo-Sik Choiwww.deepnoid.comDEEPNOID Inc.は医療用人工知能ソリューションを提供している。DEEP:NEURO、DEEP:LUNG、DEEP:SPINE、DEEP:CHEST、DEEP:BREAST、DEEP:ENDO、DEEP:DENTAL、DEEP:FUNDUS、DEEP:PATH、DEEP LIVERの名称でソリューションを提供している。同社のソリューションは、CT、MRI、X線などの医用画像、病気に関連する細胞や組織を扱った病理画像、病院の電子カルテ（EMR）など、病気に関連する臨床データを分析する。同社は2008年に設立され、韓国のソウルに本社を置いている。もっと見るDEEPNOID Inc. 基礎のまとめDEEPNOID の収益と売上を時価総額と比較するとどうか。A315640 基礎統計学時価総額₩48.32b収益（TTM）-₩11.12b売上高(TTM)₩6.87b7.0xP/Sレシオ-4.3xPER（株価収益率A315640 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計A315640 損益計算書（TTM）収益₩6.87b売上原価₩2.54b売上総利益₩4.33bその他の費用₩15.45b収益-₩11.12b直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-378.62グロス・マージン63.06%純利益率-161.93%有利子負債／自己資本比率27.1%A315640 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/21 05:32終値2026/08/21 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋DEEPNOID Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Se Hoon SohnNH Investment & Securities Co., Ltd.Jun Ki BaekNH Investment & Securities Co., Ltd.Sun-Jae HeoSK Securities Co., Ltd.
New Risk • Aug 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.5% per year over the past 5 years. Shareholders have been substantially diluted in the past year (30% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (₩6.9b revenue, or US$4.8m). Market cap is less than US$100m (₩50.8b market cap, or US$35.9m).
New Risk • Jun 01New major risk - Revenue and earnings growthEarnings have declined by 1.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.5% per year over the past 5 years. Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₩6.9b revenue, or US$4.6m). Market cap is less than US$100m (₩83.1b market cap, or US$55.1m).
New Risk • Apr 01New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₩7.5b (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₩7.5b revenue, or US$5.0m). Market cap is less than US$100m (₩96.9b market cap, or US$64.3m).
New Risk • Jan 03New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 31% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩97.2b market cap, or US$67.4m).
お知らせ • Dec 16DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 19.720256 billion.DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 19.720256 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 6,108,016 Price\Range: KRW 2885 Security Name: Common Stock Security Type: Common Stock Securities Offered: 727,428 Price\Range: KRW 2885 Transaction Features: Rights Offering
分析記事 • Dec 12Does DEEPNOID (KOSDAQ:315640) Have A Healthy Balance Sheet?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
New Risk • Aug 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.5% per year over the past 5 years. Shareholders have been substantially diluted in the past year (30% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (₩6.9b revenue, or US$4.8m). Market cap is less than US$100m (₩50.8b market cap, or US$35.9m).
New Risk • Jun 01New major risk - Revenue and earnings growthEarnings have declined by 1.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 1.5% per year over the past 5 years. Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₩6.9b revenue, or US$4.6m). Market cap is less than US$100m (₩83.1b market cap, or US$55.1m).
New Risk • Apr 01New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₩7.5b (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₩7.5b revenue, or US$5.0m). Market cap is less than US$100m (₩96.9b market cap, or US$64.3m).
New Risk • Jan 03New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 31% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩97.2b market cap, or US$67.4m).
お知らせ • Dec 16DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 19.720256 billion.DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 19.720256 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 6,108,016 Price\Range: KRW 2885 Security Name: Common Stock Security Type: Common Stock Securities Offered: 727,428 Price\Range: KRW 2885 Transaction Features: Rights Offering
分析記事 • Dec 12Does DEEPNOID (KOSDAQ:315640) Have A Healthy Balance Sheet?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
New Risk • Nov 29New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩9.7b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩9.7b free cash flow). Minor Risk Market cap is less than US$100m (₩87.7b market cap, or US$59.7m).
お知らせ • Sep 09DEEPNOID Inc. has filed a Follow-on Equity Offering in the amount of KRW 27.000004 billion.DEEPNOID Inc. has filed a Follow-on Equity Offering in the amount of KRW 27.000004 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 6,835,444 Price\Range: KRW 3950 Discount Per Security: KRW 35.55 Transaction Features: Rights Offering
New Risk • Jul 04New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩136.2b (US$100.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩17b free cash flow). Minor Risks Share price has been volatile over the past 3 months (9.4% average weekly change). Market cap is less than US$100m (₩136.2b market cap, or US$100.0m).
分析記事 • Mar 31Is DEEPNOID (KOSDAQ:315640) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
New Risk • Mar 28New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩141.7b (US$96.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (₩141.7b market cap, or US$96.5m).
お知らせ • Mar 01DEEPNOID Inc., Annual General Meeting, Mar 28, 2025DEEPNOID Inc., Annual General Meeting, Mar 28, 2025, at 09:30 Tokyo Standard Time. Location: conference room, guro-gu, seoul South Korea
Reported Earnings • Nov 15Third quarter 2024 earnings released: ₩76.00 loss per share (vs ₩86.00 loss in 3Q 2023)Third quarter 2024 results: ₩76.00 loss per share. Revenue: ₩3.98b (up ₩3.49b from 3Q 2023). Net loss: ₩1.70b (loss widened 5.3% from 3Q 2023). Revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Healthcare Services industry in Asia.
New Risk • Aug 02New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩125.8b (US$92.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). Revenue is less than US$5m (₩2.1b revenue, or US$1.6m). Market cap is less than US$100m (₩125.8b market cap, or US$92.1m).
New Risk • Nov 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risks Shareholders have been diluted in the past year (16% increase in shares outstanding). Revenue is less than US$5m (₩3.2b revenue, or US$2.5m).
お知らせ • Oct 26DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 22.59 billion.DEEPNOID Inc. has completed a Follow-on Equity Offering in the amount of KRW 22.59 billion. Security Name: Common Shares Security Type: Common Stock Securities Offered: 1,500,000 Price\Range: KRW 15060 Transaction Features: Subsequent Direct Listing
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
